Form D · Other Technology
Isracann Biosciences Inc.
Vancouver, A1 · CIK 0001726529
Offering snapshot reported Nov 14, 2022 · SEC filing
- Reported sold
- $3.74K Offering amount: $7.78K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 4, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 14, 2022 | Initial | $3,737 | No comparison | 2 | SEC filing |
| May 30, 2019 | Initial | $393,221 | No comparison | 26 | SEC filing |
| Jan 22, 2019 | Initial | $549,928 | No comparison | 61 | SEC filing |
| Dec 27, 2017 | Initial | $508,638 | No comparison | 62 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-464580
Total Offering Amount represents aggregate price of Units (101,000 x $0.037|C$0.05) plus exercise price of Warrants (101,000 x $0.040|C$0.055). There is no assurance that the Warrants, expiring Nov. 4, 2026, will be exercised.
Units, each consisting of one common share and one warrant ("Warrant"). Each Warrant is exercisable to purchase one common share at $0.055 for a period of 48 months from date of issuance.
Source: Form D, filed Nov 14, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Desmond Balakrishnan | Director |
| Sean Bromley | Director |
| Matthew Chatterton | Executive |
| Phil Floucault | Director, Executive |
| Arbel Irit | Director |
| Charlie Kiser | Executive |
| Yana Popova | Director, Executive |
| Frederick Stearman | Director, Executive |
| James Thompson | Executive |
| John Veltheer | Director |
| George Vrabec | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1600 595 Burrard Street
Vancouver, A1, V7X 1L3
Vancouver, A1, V7X 1L3